CGH
INSM icon

Crossmark Global Holdings’s Insmed INSM Stock Holding History

Crossmark Global Holdings’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$346K Buy
3,245
+33
+1% +$4K ﹤0.01% 1011
2026
Q1 		$525K Buy
3,212
+258
+9% +$39.7K 0.01% 811
2025
Q4 		$514K Buy
2,954
+761
+35% +$139K 0.01% 822
2025
Q3 		$316K Buy
+2,193
New +$269K ﹤0.01% 1076

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Crossmark Global Holdings's INSM Position: Q2 2026 in Review

Crossmark Global Holdings increased its Insmed (INSM) stake by 1% in Q2 2026, buying an estimated $4K and bringing the position to 3,245 shares worth $346K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Crossmark Global Holdings first reported a position in INSM in Q3 2025 and has held it in 4 quarters since. The position peaked at $525K in Q1 2026. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Crossmark Global Holdings held 3,245 shares of Insmed worth $346K as of Q2 2026.
  • Crossmark Global Holdings bought 33 Insmed shares in Q2 2026, an estimated $4K.
  • Insmed made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1011 holding.
  • Crossmark Global Holdings first reported a position in Insmed in Q3 2025 and has held it in 4 quarters since.
  • Crossmark Global Holdings's Insmed position peaked at $525K in Q1 2026.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.